Sidney is advisor at Singapore’s Agency for Science, Technology and Research (A*STAR), Innovation & Enterprise division and founding CEO of Diagnostics Development (DxD) Hub, a national platform hosted by A*STAR. DxD Hub is a design, development and productisation hub for diagnostics solutions, with expertise and capability to rapidly translate R&D output from public and private sectors, into deployable medtech products. Sidney is founding co-chair of the ASEAN Diagnostics Development Initiative, as well as Adjunct Associate Professor at the Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School, and Adjunct Associate Professor, NUS YLL School of Medicine (O&G) Sidney was lead of the Diagnostics Co-Operative of the Programme for Research in Epidemic Preparedness And Response (PREPARE), Singapore. PREPARE is Singapore’s national platform focusing on strengthening mid- to long-term R&D capabilities to prevent, prepare for and respond to future epidemics. Prior to joining A*STAR, Sidney co-founded and helped grow a number of startups in the biotech/medtech space. During her tenure at EDB Investments, Sidney led several investments in early stage companies in genomics, drug development and medical devices.